Small cell lung cancer transformation during antitumor therapies: A systematic review

Lung cancer is the most common cause of cancer-related death. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major histological categories of lung cancers. Drug resistance is a great challenge for cancer treatment, and histological transformation from NSCLC to SCLC...

Full description

Bibliographic Details
Main Authors: Chai Xing, Zhang Xinru, Li Wenqian, Chai Jin
Format: Article
Language:English
Published: De Gruyter 2021-08-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2021-0321
_version_ 1797998374832570368
author Chai Xing
Zhang Xinru
Li Wenqian
Chai Jin
author_facet Chai Xing
Zhang Xinru
Li Wenqian
Chai Jin
author_sort Chai Xing
collection DOAJ
description Lung cancer is the most common cause of cancer-related death. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major histological categories of lung cancers. Drug resistance is a great challenge for cancer treatment, and histological transformation from NSCLC to SCLC is one of the mechanisms underlying drug resistance in NSCLC patients. SCLC-transformed patients show combined characteristics of NSCLC and SCLC; however, they lack timely diagnoses and effective treatment strategies. Thus, we reviewed the clinical characteristics of SCLC transformation patients with a literature search to enhance clinical consciousness, diagnosis, and personalized treatment for patients with it.
first_indexed 2024-04-11T10:47:42Z
format Article
id doaj.art-7c7b5d0ce5b64da0a7fff78444a2a7a8
institution Directory Open Access Journal
issn 2391-5463
language English
last_indexed 2024-04-11T10:47:42Z
publishDate 2021-08-01
publisher De Gruyter
record_format Article
series Open Medicine
spelling doaj.art-7c7b5d0ce5b64da0a7fff78444a2a7a82022-12-22T04:29:00ZengDe GruyterOpen Medicine2391-54632021-08-011611160116710.1515/med-2021-0321Small cell lung cancer transformation during antitumor therapies: A systematic reviewChai Xing0Zhang Xinru1Li Wenqian2Chai Jin3Department of Procurement Center, The Second Hospital of Jilin University, Changchun, 130041, ChinaDepartment of Pharmacy, The Second Hospital of Jilin University, Changchun, Jilin, 130041, ChinaDepartment of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, ChinaDepartment of Pharmacy, The Second Hospital of Jilin University, No.218 Ziqiang Street, Nanguan District, Changchun, Jilin, 130041, ChinaLung cancer is the most common cause of cancer-related death. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major histological categories of lung cancers. Drug resistance is a great challenge for cancer treatment, and histological transformation from NSCLC to SCLC is one of the mechanisms underlying drug resistance in NSCLC patients. SCLC-transformed patients show combined characteristics of NSCLC and SCLC; however, they lack timely diagnoses and effective treatment strategies. Thus, we reviewed the clinical characteristics of SCLC transformation patients with a literature search to enhance clinical consciousness, diagnosis, and personalized treatment for patients with it.https://doi.org/10.1515/med-2021-0321transformationnsclcsclc
spellingShingle Chai Xing
Zhang Xinru
Li Wenqian
Chai Jin
Small cell lung cancer transformation during antitumor therapies: A systematic review
Open Medicine
transformation
nsclc
sclc
title Small cell lung cancer transformation during antitumor therapies: A systematic review
title_full Small cell lung cancer transformation during antitumor therapies: A systematic review
title_fullStr Small cell lung cancer transformation during antitumor therapies: A systematic review
title_full_unstemmed Small cell lung cancer transformation during antitumor therapies: A systematic review
title_short Small cell lung cancer transformation during antitumor therapies: A systematic review
title_sort small cell lung cancer transformation during antitumor therapies a systematic review
topic transformation
nsclc
sclc
url https://doi.org/10.1515/med-2021-0321
work_keys_str_mv AT chaixing smallcelllungcancertransformationduringantitumortherapiesasystematicreview
AT zhangxinru smallcelllungcancertransformationduringantitumortherapiesasystematicreview
AT liwenqian smallcelllungcancertransformationduringantitumortherapiesasystematicreview
AT chaijin smallcelllungcancertransformationduringantitumortherapiesasystematicreview